These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17543526)

  • 1. Synthesis and antitumour activity of new tiazofurin analogues bearing a 2,3-anhydro functionality in the furanose ring.
    Popsavin M; Spaić S; Svircev M; Kojić V; Bogdanović G; Popsavin V
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4123-7. PubMed ID: 17543526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-(3-Amino-3-deoxy-beta-D-xylofuranosyl)thiazole-4-carboxamide: a new tiazofurin analogue with potent antitumour activity.
    Popsavin M; Spaić S; Svircev M; Kojić V; Bogdanović G; Popsavin V
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5317-20. PubMed ID: 16908146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new C-nucleoside analogue of tiazofurin: synthesis and biological evaluation of 2-beta-D-ribofuranosylimidazole-4-carboxamide (imidazofurin).
    Franchetti P; Marchetti S; Cappellacci L; Yalowitz JA; Jayaram HN; Goldstein BM; Grifantini M
    Bioorg Med Chem Lett; 2001 Jan; 11(1):67-9. PubMed ID: 11140736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of 2-(3'-azido- and 3'-amino-3'-deoxy-beta-D-ribofuranosyl)thiazole-4-carboxamide.
    Liang CW; Kim MJ; Jeong LS; Chun MW
    Nucleosides Nucleotides Nucleic Acids; 2003 Nov; 22(11):2039-48. PubMed ID: 14680026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and in vitro antitumour screening of 2-(β-D-xylofuranosyl)thiazole-4-carboxamide and two novel tiazofurin analogues with substituted tetrahydrofurodioxol moiety as a sugar mimic.
    Popsavin M; Spaić S; Svirčev M; Kojić V; Bogdanović G; Popsavin V
    Bioorg Med Chem Lett; 2012 Nov; 22(21):6700-4. PubMed ID: 23010263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, conformational analysis, and biological activity of C-thioribonucleosides related to tiazofurin.
    Franchetti P; Marchetti S; Cappellacci L; Jayaram HN; Yalowitz JA; Goldstein BM; Barascut JL; Dukhan D; Imbach JL; Grifantini M
    J Med Chem; 2000 Apr; 43(7):1264-70. PubMed ID: 10753464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antiproliferative activity of two new tiazofurin analogues with 2'-amido functionalities.
    Popsavin M; Torović L; Svircev M; Kojić V; Bogdanović G; Popsavin V
    Bioorg Med Chem Lett; 2006 May; 16(10):2773-6. PubMed ID: 16495053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of 3'-deoxy-3'-C-hydroxymethyl analogues of tiazofurin and ribavirin.
    Chun MW; Kim MJ; Shin JH; Jeong LS
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):975-7. PubMed ID: 16248075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the IMP-dehydrogenase inhibitor, Tiazofurin, in bcr-abl positive acute myelogenous leukemia. Part II. In vitro studies.
    Wright DG; Boosalis M; Malek K; Waraska K
    Leuk Res; 2004 Nov; 28(11):1137-43. PubMed ID: 15380336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure based design, synthesis and in vitro antitumour activity of tiazofurin stereoisomers with nitrogen functions at the C-2' or C-3' positions.
    Kojić V; Popsavin M; Spaić S; Jakimov D; Kovačević I; Svirčev M; Aleksić L; Zelenović BS; Popsavin V
    Eur J Med Chem; 2019 Dec; 183():111712. PubMed ID: 31557614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new tiazofurin pronucleotide: synthesis and biological evaluation of cyclosaligenyl-tiazofurin monophosphate.
    Cappellacci L; Barboni G; Franchetti P; Martini C; Jayaram HN; Grifantini M
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):869-72. PubMed ID: 14565299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
    Franchetti P; Cappellacci L; Grifantini M; Barzi A; Nocentini G; Yang H; O'Connor A; Jayaram HN; Carrell C; Goldstein BM
    J Med Chem; 1995 Sep; 38(19):3829-37. PubMed ID: 7562914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of biochemical parameters of benzamide riboside, a new inhibitor of IMP dehydrogenase, with tiazofurin and selenazofurin.
    Gharehbaghi K; Sreenath A; Hao Z; Paull KD; Szekeres T; Cooney DA; Krohn K; Jayaram HN
    Biochem Pharmacol; 1994 Oct; 48(7):1413-9. PubMed ID: 7945441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and in vitro antitumour activity of tiazofurin analogues with nitrogen functionalities at the C-2' position.
    Popsavin M; Kojić V; Torović L; Svirčev M; Spaić S; Jakimov D; Aleksić L; Bogdanović G; Popsavin V
    Eur J Med Chem; 2016 Mar; 111():114-25. PubMed ID: 26859071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleoside and non-nucleoside IMP dehydrogenase inhibitors as antitumor and antiviral agents.
    Franchetti P; Grifantini M
    Curr Med Chem; 1999 Jul; 6(7):599-614. PubMed ID: 10390603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential impact of tiazofurin and ribavirin on the enzymic program of the bone marrow.
    Prajda N; Hata Y; Abonyi M; Singhal RL; Weber G
    Cancer Res; 1993 Dec; 53(24):5982-6. PubMed ID: 7903199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo synthesis of two new cytotoxic tiazofurin analogues with modified sugar moieties.
    Popsavin M; Torović L; Kojić V; Bogdanović G; Spaić S; Popsavin V
    Bioorg Med Chem Lett; 2003 Oct; 13(19):3167-70. PubMed ID: 12951086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing binding requirements of type I and type II isoforms of inosine monophosphate dehydrogenase with adenine-modified nicotinamide adenine dinucleotide analogues.
    Chen L; Gao G; Felczak K; Bonnac L; Patterson SE; Wilson D; Bennett EM; Jayaram HN; Hedstrom L; Pankiewicz KW
    J Med Chem; 2007 Nov; 50(23):5743-51. PubMed ID: 17958343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical consequences of resistance to tiazofurin in human myelogenous leukemic K562 cells.
    Jayaram HN; Zhen W; Gharehbaghi K
    Cancer Res; 1993 May; 53(10 Suppl):2344-8. PubMed ID: 8097964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tiazofurin: molecular and clinical action.
    Weber G; Prajda N; Abonyi M; Look KY; Tricot G
    Anticancer Res; 1996; 16(6A):3313-22. PubMed ID: 9042306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.